X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-12-28 | ATHA | Mileson Glenna | CFO | P - Purchase | $2.85 | +50,000 | 159,930 | +45% | +$142,250 | ||||||
2022-12-02 | ATHA | Romano Kelly A | Dir | P - Purchase | $3.29 | +30,000 | 38,315 | +361% | +$98,700 | ||||||
2022-11-15 | ATHA | Moebius Hans | Chief Medical Officer | P - Purchase | $3.29 | +5,000 | 65,836 | +8% | +$16,442 | ||||||
| M | 2022-06-29 | ATHA | Perceptive Advisors LLC | Dir, 10% | P - Purchase | $2.99 | +1,371,362 | 4,797,278 | +40% | +$4,100,372 | |||||
2022-06-28 | ATHA | Moebius Hans | Chief Medical Officer | P - Purchase | $2.88 | +10,000 | 52,955 | +23% | +$28,800 | ||||||
2022-06-23 | ATHA | Worthington Mark | GC | S - Sale | $2.69 | -2,614 | 19,097 | -12% | -$7,032 | ||||||
2022-06-23 | ATHA | Mileson Glenna | CFO | S - Sale | $2.69 | -2,614 | 109,167 | -2% | -$7,032 | ||||||
2022-06-23 | ATHA | Litton Mark James | CEO | S - Sale | $2.69 | -7,960 | 148,244 | -5% | -$21,412 | ||||||
2022-06-23 | ATHA | Lenington Rachel | COO | S - Sale | $2.69 | -4,193 | 5,807 | -42% | -$11,279 | ||||||
2022-06-23 | ATHA | Church Kevin | EVP, Research | S - Sale | $2.69 | -2,614 | 57,695 | -4% | -$7,032 | ||||||
2022-03-31 | ATHA | Romano Kelly A | Dir | P - Purchase | $13.11 | +8,000 | 8,315 | >999% | +$104,880 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |